These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 3502432)

  • 21. Blastogenic responses of human lymphocytes to a streptococcal preparation OK-432 and its fractions.
    Tanaka T; Kaneko Y; Haba F; Katsuta S; Tsutsui K; Tamaki S; Chen DR; Suzuki S; Ueda R; Yamamoto A
    J Clin Lab Immunol; 1989 Feb; 28(2):91-6. PubMed ID: 2787407
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Su-polysaccharide skin test and immunotherapy with OK-432 in postoperative gastric cancer--the effect of a splenectomy].
    Saito H; Kikkawa H; Bando H; Sakatoku M; Hirano M; Tatsuzawa T
    Gan No Rinsho; 1988 Nov; 34(14):1965-8. PubMed ID: 3204664
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [An immunological study on the effect of simultaneous intrahepatic injection of an immunomodulator (OK-432) and adriamycin--an experiment in rats].
    Takada T; Yasuda H; Uchiyama K; Hasegawa H; Miura S; Asagoe T; Hanaue H; Shikata J
    Gan To Kagaku Ryoho; 1985 Dec; 12(12):2305-13. PubMed ID: 2934024
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [A multi-center trial of MY-1, a new biological response modifier, on the immunological parameters of postoperative gastric cancer patients].
    Ochiai T; Sato H; Isono K; Uematsu T; Nakajima K; Mukai M; Asano T; Onoda S; Morioka Y; Danno M
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 1):959-69. PubMed ID: 3963860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Orally administered streptococcal preparation, OK-432 augments the antitumor immunity of patients with gastric or colorectal cancer.
    Nio Y; Ohgaki K; Tsuchitani T; Imai S; Shiraishi T; Tobe T
    Biotherapy; 1990; 2(3):213-22. PubMed ID: 2206774
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunological differences between squamous cell cancer patients treated with and without biological response modifier (OK-432): evaluation at a period of more than one year after the last treatment.
    Yoshimura Y; Oka M; Harada T; Inou Y; Saito H; Odagawa T; Matsumoto K
    J Osaka Univ Dent Sch; 1989 Dec; 29():117-22. PubMed ID: 2577382
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of OK-432 on cytotoxic activity in cancer patients without tumor burden.
    Fujieda S; Saito H; Isobe Y; Nakagawara G; Nishi O; Nagahara K; Watanabe Y; Hoshino T
    Anticancer Res; 1992; 12(6B):1941-5. PubMed ID: 1341892
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Role of the spleen in OK-432 immunotherapy and characterization of effector cells].
    Yamagishi H; Naito K; Maeda Y; Kobayashi M; Kurioka H; Fujimori C; Tanaka T; Hashimoto I
    Gan To Kagaku Ryoho; 1983 Jul; 10(7):1670-8. PubMed ID: 6870309
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The increase of CD57+ T cells in the peripheral blood and their impaired immune functions in patients with advanced gastric cancer.
    Chochi K; Ichikura T; Majima T; Kawabata T; Matsumoto A; Sugasawa H; Kawarabayashi N; Takayama E; Hiraide H; Seki S; Mochizuki H
    Oncol Rep; 2003; 10(5):1443-8. PubMed ID: 12883721
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Augmentation of mouse natural killer cell activity by a streptococcal preparation, OK-432.
    Oshimi K; Kano S; Takaku F; Okumura K
    J Natl Cancer Inst; 1980 Dec; 65(6):1265-9. PubMed ID: 7001124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor-draining lymph nodes of primary lung cancer patients: a potent source of tumor-specific killer cells and dendritic cells.
    Kimura H; Dobrenkov K; Iida T; Suzuki M; Ando S; Yamamoto N
    Anticancer Res; 2005; 25(1A):85-94. PubMed ID: 15816523
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of human recombinant-gamma interferon on the immune function of peripheral blood lymphocytes in cancer patients].
    Yamada J; Tanaka N; Kamitani S; Goto K; Gangi J; Orita K
    Gan To Kagaku Ryoho; 1986 May; 13(5):1946-52. PubMed ID: 2939802
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A case of advanced gastric cancer responsive to intratumoral OK-432 injection].
    Sakai Y; Maeda M; Koyama W; Totsuka S; Sakamoto S; Kanayama M
    Gan To Kagaku Ryoho; 1988 Jun; 15(6):1978-80. PubMed ID: 3382244
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An evaluation of the mitogenic reactivity of intestinal intraepithelial lymphocytes of chickens.
    Agrawal PK; Reynolds DL
    Avian Dis; 1999; 43(2):172-81. PubMed ID: 10396629
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Analysis of NK cell activity, lymphocyte reactivity to mitogens and serotest PSA and TPS values in patients with primary and disseminated prostate cancer, PIN and BPH.
    Kastelan M; Kovacić K; Tarle R; Kraljić I; Tarle M
    Anticancer Res; 1997; 17(3B):1671-5. PubMed ID: 9179216
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism.
    Rook AH; Hooks JJ; Quinnan GV; Lane HC; Manischewitz JF; Macher AM; Masur H; Fauci AS; Djeu JY
    J Immunol; 1985 Mar; 134(3):1503-7. PubMed ID: 3918102
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Phenotypic and functional analysis of peripheral blood mononuclear cells in generalised aggressive and chronic periodontitis patients.
    Emingil G; Karaarslan F; Keskinoğlu A; Coker I; Atilla G
    J Int Acad Periodontol; 2001 Oct; 3(4):87-94. PubMed ID: 12666947
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunological parameters in gastric cancer patients treated with immunotherapy of streptococcal preparation OK-432.
    Hanaue H; Nomoto S; Kimura T; Kutsuna T; Takeuchi T; Yoshizaki S
    Keio J Med; 1982 Dec; 31(4):159-68. PubMed ID: 6985379
    [No Abstract]   [Full Text] [Related]  

  • 39. Adjuvant immunotherapy with a S. pyogenes preparation (OK432) in urogenital cancer patients.
    Nakagami Y; Chin H; Tannowa K; Matsumoto K; Kawai H
    Invest Urol; 1980 Mar; 17(5):386-9. PubMed ID: 6965669
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The management of malignant ascites with a streptococcal preparation, OK-432: relation between the clinical effect and auto-tumor cell killing activity by OK-432-induced ascites-derived lymphocytes].
    Katano M; Yamamoto H; Mizoguchi T; Hidaka K; Hisatsugu T; Torisu M
    Gan To Kagaku Ryoho; 1987 Aug; 14(8):2464-8. PubMed ID: 3497612
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.